Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Summit Therapeutics
Over the past year ALNY returned −62.0% and SMMT returned −7.5%; their daily moves had a correlation of 0.14.
ALNY −62.0% SMMT −7.5%Growth of $1, one year, split-adjusted
| Metric | ALNY | SMMT |
|---|---|---|
| Price | $161.08 | $16.17 |
| Market cap | $21.57B | $12.90B |
| Today | +0.74% | +2.34% |
| 1 month | −28.1% | −6.6% |
| 6 months | −46.8% | −9.4% |
| Year to date | −59.5% | −7.5% |
| 1 year | −62.9% | −11.3% |
| Revenue growth (YoY) | +16.7% | — |
| Gross margin | 75.2% | — |
| Net margin | 148.6% | — |
| P/E (TTM) | 7.9× | — |
| Price / sales | 4.3× | — |
| Net cash | $2.57B | $690.7M |
| Dividend yield | — | — |
| Volatility (60d) | 72.8% | 70.7% |
| Short % of float | 4.9% | 29.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).